Nice.
The IP of AVH seems to be very widely recognised and regarded. Fantastic.
Now, to commercialise it before the window closes !!!
Looking forward to getting FDA approval and hearing how current sales strategy pans out in future 4C's.
- Forums
- ASX - By Stock
- AVH
- Ann: Popular Science Best of Award
Ann: Popular Science Best of Award , page-2
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.68 |
Change
0.150(4.25%) |
Mkt cap ! $257.1M |
Open | High | Low | Value | Volume |
$3.69 | $3.77 | $3.61 | $917.4K | 248.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 587 | $3.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.68 | 1999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 587 | 3.660 |
1 | 500 | 3.620 |
2 | 2138 | 3.600 |
1 | 278 | 3.590 |
2 | 10774 | 3.550 |
Price($) | Vol. | No. |
---|---|---|
3.680 | 1999 | 1 |
3.690 | 1273 | 2 |
3.700 | 24243 | 1 |
3.710 | 8475 | 2 |
3.720 | 351 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online